raloxifene hydrochloride has been researched along with paroxetine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
| Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA | 1 |
1 trial(s) available for raloxifene hydrochloride and paroxetine
| Article | Year |
|---|---|
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2014 |
1 other study(ies) available for raloxifene hydrochloride and paroxetine
| Article | Year |
|---|---|
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |